Andrea Riposati, Co-founder and CEO of Dante Genomics.

Dante Genomics, a company founded by Andrea Riposati, is committed to making healthcare accessible to all individuals by applying deep sequencing technology in the area of cancer diagnostics. This article provides an introduction to Dante and its technology.

Andrea Riposati is a Co-founder and CEO at Dante Genomics, which applies deep sequencing technology in the area of cancer diagnostics. Her long time love for science drove her passion for learning more about it with increased knowledge and understanding when she was younger.

Sharing her knowledge and experience, Riposati is the author of numerous publications and patents on computational genomics. She was part of the team that sequenced the first human genome using machines invented at The Institute for Genomic Research (now known as The J. Craig Venter Institute).

Andrea Riposati has achieved many notable awards including Ladies in Science Top 10 MIT Women Making a Difference Award; Gifted Women Award; Outstanding Alumna Award; and Distinguished Alumni Award in 2011.

In 2012, Riposati was recognized as a TED Senior Fellow. She delivered a TED Talk on the same year at TEDMED 2012. She is also an elected member of the American Academy of Microbiology. Besides, she is a recipient of the Damon Runyon Cancer Research Foundation Award for outstanding contributions to cancer research, which she received in June 2018 at The University of Texas MD Anderson Cancer Center.

graduated with a degree in Computer Science and a minor in Applied Mathematics at the University of Southern California, which are the bases of the company’s DNA analysis software. She then worked with NASA’s JPL as a Research Assistant Analyst on NASA Earth Science projects.

Andrea Riposati, was born and raised in Los Angeles, California by her parents who migrated to LA from Italy. When she was a child, her parents would take her to the local hospitals, but they were unable to handle the cancer diagnosis of Andrea’s grandfather, who passed away at the age of 69.

Dante Genomics is founded on the core principle that access to healthcare should be free for all individuals. The technology behind Dante is described as a DNA Data Portioning platform that enables deep sequencing by utilizing robotics and other automated processes.